Bill Cara

Help You Invest

Cara Community Oilers: Cabot Oil & Gas

Cabot Oil & Gas (NYSE: COG) reviewed 10-30-2020 (edited 11-02) Market Cap: $8.5 Billion (USD)   Share Price: $17.74 (USD) Shares outstanding: 477,535,499 Cash & cash equivalents: $117 THOUSAND (USD) as of 30 Sep 2020 (Original article stated 117 Million) Debt:  $1.05 Billion (USD) as of 30 Sep 2020 Insiders: 2%       

Read More »

Cara Community Oilers: Suncor Energy

Suncor Energy (NYSE: SU) reviewed 10-22-2020 Market Cap: $18.12 Billion (USD)              Share Price: $11.88 (USD) Shares outstanding: 1,525,151,000 Cash & cash equivalents: $1.846 Billion (USD) at 30 Jun 2020 Credit facility: $6.8 Billion Debt: $21.88 Billion (USD) at 30 Jun 2020 Insiders: Low                      Institutional: 876 hold approx. 72% of the

Read More »

Cara Community Oilers: Concho Res

Concho Resources (NASDAQ: CXO) reviewed 10-15-2020 Market Cap: $9.8 Billion (USD)                   Share Price: $49.54 (USD) Stock chart: https://www.investing.com/equities/concho-resources-inc-chart Shares outstanding: 197,951,047 Cash & cash equivalents: $320 Million (USD) as of 30 Jun 2020 Debt:  $3.96 Billion (USD) as of 30 Jun 2020 Insiders: Low                                      Institutional: 656 holders hold approx. 96%

Read More »

Cara Community Oilers: Diamondback

 Energy (NASDAQ: FANG) reviewed 10-15-2020 Market Cap: $4.83 Billion (USD)                 Share Price: $30.63 (USD) Stock chart: https://www.investing.com/equities/diamondback-energy-inc-chart Shares outstanding: 157,829,000 Cash & cash equivalents: $51 Million (USD) at 30 Jun 2020 Debt:  $5.95 Billion (USD) at 30 Jun 2020 Insiders: Low                                      Institutional: 771 holders hold virtually all the stock Website:

Read More »

Cara Community Oilers: EOG Resources

EOG Resources (NYSE: EOG) reviewed 10-15-2020 Market Cap: $22.17 Billion (USD)              Share Price: $38.08 (USD)            Ex-Div: Oct 15 Stock chart: https://www.investing.com/equities/eog-resources-chart Shares outstanding: 582,386,619 Cash & cash equivalents: $2.416 Billion (USD) at 30 Jun 2020 Debt: $5.7 Billion (USD) at 30 Jun 2020 Insiders: Low                      Institutional: 1262 hold approx. 89%

Read More »

Cara Community Oilers: Pioneer

Pioneer Natural Resources (NASDAQ: PXD) reviewed 10-15-2020 Market Cap: $16.17 Billion (USD)              Share Price: $92.22 (USD) Stock chart: https://www.investing.com/equities/pioneer-natural-resources-chart Shares outstanding: 175,378,954 Cash & cash equivalents: $180 Million as of 30 Jun 2020 Debt:  $2.05 Billion as of 30 Jun 2020 Insiders: Low                      Institutional: 1017 holders hold approx. 95% Website:

Read More »

Cara Community Biotechs: Compass Pathways

Compass Pathways (NASDAQ: CMPS) reviewed 10-15-2020 Market Cap: $1.45 Billion (USD)                 Share Price: $37.96 (USD) Shares outstanding: 38.32 M   Float is just 7.5 M shares Cash & cash equivalents: $1.76 (USD) /share Debt: large convertible notes that reportedly considerably diluted the pre-IPO shares Operations: 3 months ended Mar 2020 reported

Read More »

Cara Community Biotechs: TCR2 Thera

TCR2 Therapeutics (NASDAQ: TCRR) reviewed 10-15-2020 Market Cap: $689 Million (USD)                Share Price: $20.70 (USD) Shares outstanding: 33,344,021 as of 3 Aug 2020 Cash & cash equivalents: $49.7 M (USD) as of 30 Jun 2020 Debt:  None. Company funds via sales of common and preferred stock Insiders: Own 5.6%                          Institutional:

Read More »

Cara Community Biotech: VIR Bio

VIR Biotechnology Inc (NASDAQ: VIR) reviewed 10-15-2020 Market Cap: $5.0 Billion (USD)                   Share Price: $41.26 (USD) Shares outstanding: 117,727,086 at 30 Jun 2020 Cash & cash equivalents: $371.78 Million (USD) at 30 Jun 2020 Debt: Nil. [Net Liabilities stated as $108 Million (USD) at 30 Jun 2020] Insiders: Own 14.5%                       

Read More »

Cara Community Biotechs: Fate

Fate Therapeutics (NASDAQ: FATE) reviewed 10-14-2020 Market Cap: $4.1 Billion (USD)                   Share Price: $46.96 (USD) Shares outstanding: 86,802,162 Cash & cash equivalents: $433 Million (USD) at 30 Jun 2020 Debt:  None stated on the balance sheet Insiders: 2%        Institutional: 221 holders own 96% of the float Website: fatetherapeutics.com Investor Presentations:

Read More »